Trials / Completed
CompletedNCT02046512
Probiotics to Promote Intestinal Health
Randomized Controlled Trial of Lactobacillus Rhamnosus GG to Promote Intestinal Health
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on broad spectrum antimicrobials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | 1 capsule containing 10 billion cells of Lactobacillus rhamnosus GG on a twice-daily basis |
| OTHER | Placebo | Sugar pill |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-10-01
- Completion
- 2018-12-01
- First posted
- 2014-01-27
- Last updated
- 2022-04-04
- Results posted
- 2022-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02046512. Inclusion in this directory is not an endorsement.